Biotech
DUBLIN, IRELAND and OSAKA, JAPAN: Deal Provides Takeda Global Rights to Selective 5-HT4 Agonist; Highlights Takeda's Commitment to Gastroenterology as a Core Therapeutic Area
...
WALTHAM, MA: Life Sciences Analytics Industry Veteran Will Drive Technology Innovation and Product Strategy for Customer Benefit
...
SEATTLE, WA: Oral Endoxifen for Patients Refractory to Tamoxifen
...
NEW YORK, NY: Trial Represents Kadmon's Entry Into Clinical Fibrosis Research
...
DUBLIN, IRELAND: Theravance Biopharma Entitled to Receive 85% Economic Interest in Royalties Paid by GSK as Part of Agreement With Innoviva
...
MARLBOROUGH, MA: Enhances Ability to Supply Early Drug Development Programs While Shortening Project Timelines
...
BETHESDA, MD: Company Names Dr. Menghis Bairu Executive Chairman
...
